دورية أكاديمية

A phase 2 clinical trial of the heat shock protein 90 (HSP 90) inhibitor ganetespib in patients with refractory advanced esophagogastric cancer

التفاصيل البيبلوغرافية
العنوان: A phase 2 clinical trial of the heat shock protein 90 (HSP 90) inhibitor ganetespib in patients with refractory advanced esophagogastric cancer
المؤلفون: Goyal, Lipika, Chaudhary, Surendra Pal, Kwak, Eunice L., Abrams, Thomas A., Carpenter, Amanda N., Wolpin, Brian M., Wadlow, Raymond C., Allen, Jill N., Heist, Rebecca, McCleary, Nadine Jackson, Chan, Jennifer A., Goessling, Wolfram, Schrag, Deborah, Ng, Kimmie, Enzinger, Peter C., Ryan, David P., Clark, Jeffrey W.
المساهمون: National Cancer Institute
المصدر: Investigational New Drugs ; volume 38, issue 5, page 1533-1539 ; ISSN 0167-6997 1573-0646
بيانات النشر: Springer Science and Business Media LLC
سنة النشر: 2020
مصطلحات موضوعية: Pharmacology (medical), Pharmacology, Oncology
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1007/s10637-019-00889-y
DOI: 10.1007/s10637-019-00889-y.pdf
DOI: 10.1007/s10637-019-00889-y/fulltext.html
الإتاحة: https://doi.org/10.1007/s10637-019-00889-yTest
حقوق: https://www.springernature.com/gp/researchers/text-and-data-miningTest ; https://www.springernature.com/gp/researchers/text-and-data-miningTest
رقم الانضمام: edsbas.74E2A2FA
قاعدة البيانات: BASE